Drug candidate designed by NIH scientists reduced brain inflammation, protected against cognitive decline in Alzheimer’s mouse model

The study results provide new evidence that brain inflammation is a key neuropathological pathway of interest.
Click here to view original post

Advertise With Biotech Networks